Comments to the Section on Radioiodine Therapy for Differentiated Thyroid Cancer in Children of the European Thyroid Association Guidelines 2022

Abstract

Children are not  “miniature” adults!  Most experts around the  world  recognize the  differences between adult and pediatric thyroid cancer and emphasize the need for specific guidelines for the pediatric population. The American Thyroid Association (ATA) first developed separate Guidelines for the Treatment of Pediatric Thyroid Nodules and Carcinoma (hereafter, ATA Guidelines) in 2015 [1], which  has not been revised  to date. In September 2022, the European Thyroid Association (ETA) published its Guideline on the Management of Pediatric Thyroid Nodules and Differentiated Thyroid Carcinoma (hereafter, ETA Guidelines) [2]. The aim of our article, in anticipation of the revision of Russian  clinical  guidelines for the treatment of pediatric thyroid cancer,  is to inform specialists in the field of radioiodine therapy (RIT) with the key recommendations of the ETA.